206193-17-1

Basic information

• Product Name: (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide
• Synonyms: (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide;(2R)-3-bromo-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;(R)-3-bromo-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
• CAS NO: 206193-17-1
• Molecular Formula: C₁₂H₁₀BrF₃N₂O₂
• Molecular Weight: 351.1192096
• Mol File: 206193-17-1.mol
• Article Data: 30

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide(206193-17-1)
• EPA Substance Registry System: (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide(206193-17-1)

Safety Data

• Hazardous Substances Data: 206193-17-1(Hazardous Substances Data)

Usage

General Description

"(R)-3-bromo-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide" is a chemical compound with the molecular formula C11H11BrF3N2O2. It is a derivative of 2-hydroxy-2-methylpropionic acid and contains a bromo group, a cyano group, and a trifluoromethylphenyl group. (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide is likely to be used in pharmaceutical research and development due to its potential biological activity and may function as a building block for synthesizing other chemical compounds. However, specific information on its uses and potential applications is limited, and further research is needed to fully understand its properties and potential uses.

Upstream product

• 654-70-6 4-amino-2-trifluoromethylbenzonitrile 
• 1010396-30-1 (R)-3-bromo-2-hydroxy-2-methylpropanoyl chloride 
• 81026-68-8 (R)-3-bromo-2-hydroxy-2-methylpropanoic acid 
• 261904-39-6 (2R)-3-bromo-2-hydroxy-2-methylpropanoic acid 
• 927203-28-9 3-bromomethyl-3-methyl-tetrahydro-pyrrolo[2,1-c][1,4]oxazine-1,4-dione 

Relevant articles and documents

Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer

A series of propanamide derivatives were designed, synthesized, and pharmacologically characterized as selective androgen receptor degraders (SARDs) and pan-antagonists that exert a broad-scope androgen receptor (AR) antagonism. Incorporating different ba

PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT OF PROSTATE CANCER

This invention relates to pyrazolylpropanamide compounds and uses thereof for treatment of prostate cancer, advanced prostate cancer, refractory prostate cancer, AR overexpressing prostate cancer, castration-resistant prostate cancer, castration-sensitive

Synthesis method of nicotinate

The invention belongs to the technical field of compound preparation, and in particular, relates to (S)-1-((4-cyano-3-(trifluoromethyl)phenyl)amino)-3-(4-cyanophenoxy)-2-methyl-1-oxopropan-2-yl nicotinate and a synthesis method thereof. The method compris